Position in HROW
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,682,525
-$591,586 QoQ
Shares Held
180,893
-22.9% QoQ
Ownership
0.483%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 221 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. HROW ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
2,604,559 | $24,300,533 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,826,234 | $18,262,340 | |
| 3 | ZTS |
Zoetis Inc.
|
252,429 | $18,139,545 | |
| 4 | VTRS |
Viatris Inc
|
924,858 | $14,686,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
722,863 | $11,587,493 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
317,401 | $7,811,236 | |
| 7 | HROW |
Harrow, Inc.
This page
|
180,893 | $7,682,525 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
198,546 | $6,726,737 |
All Filings in HROW
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,682,525 | 180,893 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $8,274,111 | 234,660 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $10,412,157 | 212,493 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $10,970,344 | 227,695 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,576,330 | 215,335 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,142,286 | 343,695 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $13,692,459 | 408,121 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $18,310,588 | 407,264 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,340,073 | 542,847 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,890,051 | 520,790 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,838,097 | 431,973 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $4,887,121 | 340,092 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $165,901 | 11,240 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||